Identification of novel candidate regulators of human naive pluripotency by means of a genetic switch utilizing the chimeric receptor G-CSFR:GP130

This study utilizes a dual genetic switch combining a chimeric G-CSFR:gp130 receptor and hormone-dependent STAT3-ERT2 to identify novel candidate regulators, including IFI16 and IFITM proteins, that orchestrate the transition of human pluripotent stem cells to a naive state through JAK kinase-mediated signaling and epigenomic remodeling.

The Gist

Imagine human stem cells as a group of highly skilled apprentices. These apprentices have a specific job: they can turn into any type of cell in the body (heart, brain, skin). However, they come in two different "training levels":

1. Primed Apprentices (The Standard): These are the cells we usually work with in labs. They are ready to work but are "locked" into a specific mindset. To keep them from graduating (differentiating) into specific jobs, we have to constantly feed them a specific "keep working" signal (a protein called FGF2). If we stop feeding them, they panic and start specializing too early.
2. Naïve Apprentices (The Ground State): These are the "fresh out of the womb" version of stem cells. They are more flexible, more powerful, and can be kept in a state of pure potential for longer. In mice, we know how to keep these cells happy using a simple signal called LIF (Leukemia Inhibitory Factor). But in humans, LIF doesn't work well on its own.

The Big Question:
Scientists have been trying to figure out how to trick human "Primed" cells into becoming "Naïve" cells. They know that turning on a specific switch (the STAT3 pathway) helps, but they didn't know the full recipe or what other ingredients were needed to make the transformation stick.

The Experiment: A "Genetic Switch"

The researchers in this paper built a custom-made genetic switch to solve this mystery. Think of it like installing a remote control on a car that usually requires a physical key.

• The Car: The human stem cell.
• The Remote: A special receptor they engineered into the cell.
• The Signal: Instead of using the natural LIF signal, they used G-CSF (a hormone usually used to boost white blood cells) to trigger their custom receptor.
• The Second Key: They also added a "hormone-dependent" version of the STAT3 protein. This protein only turns on when they add a drug called Tamoxifen.

By pressing both buttons (adding G-CSF and Tamoxifen), they could force the human stem cells to switch from "Primed" to "Naïve" without needing the natural LIF signal.

The Discovery: What Happens Inside?

Once they flipped the switch, they watched the cells closely to see what happened in the first few hours. It was like watching a house get renovated in fast-forward.

1. The "JAK" Foreman is Essential
They found that for the renovation to start, a specific construction foreman named JAK kinase had to be recruited to the site.

• The Analogy: Imagine the G-CSF signal is a construction crew arriving at a house. The JAK kinase is the foreman who unlocks the front door and tells the workers, "Okay, we can start knocking down walls!"
• The Result: If they removed the JAK foreman, the crew arrived, but nothing happened. The house (the cell's DNA) remained locked up, and the cells couldn't become Naïve.

2. The "Chromatin" Locksmith
The JAK foreman's job was to act as a locksmith. The DNA in a "Primed" cell is tightly wrapped up like a ball of yarn (methylation), making it hard to read. The JAK signal loosened this yarn (reduced DNA methylation), allowing the cell to read new instructions. This "opening up" of the DNA was the first step to becoming Naïve.

3. The "Early Response" Team (The 26 Genes)
Once the doors were unlocked, a specific team of 26 genes woke up immediately. These weren't the famous "Naïve" genes everyone knows (like OCT4 or NANOG); these were the early responders that prepared the cell for the change.

• The Analogy: These are like the movers and packers who arrive before the actual renovation crew. They start clearing out the old furniture and setting up the new layout.
• The Surprise: Many of these genes are part of the body's immune defense system (Interferon-stimulated genes). It turns out that to stay in this "pure potential" state, the cells might be using ancient immune defenses to protect their genetic blueprint from viruses or damage, ensuring the "germline" (the future of the species) stays safe.

Why Does This Matter?

This study is like finding the blueprint for a new type of engine.

• Better Tools: Now that we know exactly which genes (like IFI16 and IFITM proteins) are needed to start the Naïve state, scientists can create better, more stable human stem cells for research.
• Understanding Life: It helps us understand how a single fertilized egg (which is Naïve) decides to become a complex human being.
• Medical Applications: These "Naïve" cells are better at being edited and turned into specific tissues for treating diseases. By understanding the "switch," we can make these cells more reliable for regenerative medicine.

In a Nutshell:
The researchers built a remote control to force human stem cells to reset to their most powerful, flexible state. They discovered that this reset requires a specific "foreman" (JAK) to unlock the cell's DNA, which then wakes up a team of "immune-savvy" movers (the 26 genes) to prepare the cell for its new, super-flexible life.

Technical Summary

1. Problem Statement

Human pluripotent stem cells (hPSCs) exist primarily in a "primed" state, which differs significantly from the "naïve" state found in the pre-implantation epiblast. While various chemical protocols (e.g., 5iLAF, 2iL) have successfully converted primed hPSCs to a naïve-like state, the early molecular mechanisms driving this transition remain poorly understood. Specifically:

• It is unclear whether the activation of the LIF/JAK/STAT3 pathway alone is sufficient to initiate the naïve program in human cells.
• The specific early-response genes and epigenetic remodeling events required to transition from primed to naïve pluripotency have not been fully delineated.
• Existing methods rely on complex chemical cocktails, making it difficult to isolate the specific contribution of signaling pathways versus chemical inhibitors.

2. Methodology

The authors developed a dual genetic switch system to precisely control the transition from primed to naïve pluripotency in human embryonic stem cells (hESCs), specifically using the OS3 cell line.

• Genetic Components:
  1. STAT3-ERT2: A hormone-dependent fusion protein activated by tamoxifen (4-OHT).
  2. Chimeric Receptor (GCSFR:gp130): A receptor fusing the extracellular domain of the human Granulocyte Colony-Stimulating Factor Receptor (G-CSFR) with the cytoplasmic domain of the mouse gp130 signal transducer. This receptor dimerizes upon G-CSF binding, recruiting intracellular signaling factors.
• Experimental Design:
  • Induction: Cells were treated with G-CSF (to activate the chimeric receptor) and Tamoxifen (to activate STAT3-ERT2) in the absence of FGF2.
  • Mutant Analysis: To dissect signaling requirements, the authors generated stable cell lines expressing mutant versions of the GCSFR:gp130 receptor with specific deletions or point mutations to block the recruitment of:
    • STAT3 (Y126-275F)
    • SHP2 (Y118F)
    • HCK (Δ122-171)
    • YES (Δ172-187)
    • JAK kinases (Δ13-18)
    • A "short" variant retaining only the JAK binding site.
  • Omics & Functional Assays:
    • RNA-seq: Performed at 12h and 24h post-induction to identify early response genes.
    • Epigenetic Profiling: Immunofluorescence and Western blotting to measure DNA methylation (5mC, 5hmC) and histone modifications (H3K9me3).
    • Loss-of-Function: Lentiviral shRNA knockdown and CRISPRoff (dCas9-KRAB-DNMT3A/3L) mediated repression of candidate genes to assess their role in self-renewal and proliferation.

3. Key Contributions

1. Development of a Robust Genetic Switch: The study establishes a LIF-independent, chemically defined system (G-CSF + Tamoxifen) that mimics LIF signaling to drive naïve conversion, proving that the GCSFR:gp130 chimera functionally substitutes for LIFR.
2. Identification of JAK as the Critical Driver: The authors demonstrate that JAK kinase recruitment to the gp130 cytoplasmic tail is the absolute requirement for naïve conversion. Recruitment of STAT3, SHP2, HCK, or YES is dispensable for the initiation of the transcriptional program (as STAT3-ERT2 provides the STAT3 function).
3. Discovery of Early Response Genes: The study identifies a specific set of 26 early-response genes (including interferon-stimulated genes) that are upregulated within 24 hours of transition, distinct from canonical naïve markers (like KLF4 or TFCP2L1) which appear later.
4. Epigenetic Mechanism: The paper elucidates that JAK signaling is required to reduce DNA methylation (5mC) and repressive histone marks (H3K9me3), thereby "opening" the chromatin to allow STAT3-ERT2 binding and transcriptional activation.

4. Key Results

• Synergistic Activation: G-CSF alone or Tamoxifen alone failed to maintain pluripotency in FGF2-deprived conditions. Only the combination of G-CSF + Tamoxifen sustained self-renewal and upregulated naïve markers (e.g., ESRRB, DPPA5, KLF2, NANOG).
• Transcriptomic Clustering: RNA-seq revealed that combinatorial treatment (G-CSF + Tamoxifen) induced a distinct transcriptional cluster within 12–24 hours.
• The 26 Early Genes: A subset of 26 genes was identified as highly enriched in the human epiblast and induced early during reprogramming. These included:
  • Interferon-stimulated genes (ISGs): IFI16, IFITM1, IFITM2, IFITM3, PLSCR1, NMI.
  • Other regulators: BHLHE40, PROM1, VWA1, OSMR, BANCR, SERPING1.
• JAK Dependency:
  • Mutant receptors unable to recruit JAK (ΔJAK) failed to upregulate the 26 early genes and underwent differentiation.
  • Mutants lacking STAT3, SHP2, HCK, or YES recruitment still successfully upregulated these genes and maintained pluripotency, provided JAK recruitment was intact.
• Epigenetic Remodeling:
  • In JAK-deficient cells, 5mC levels increased and 5hmC levels decreased, indicating a failure in DNA demethylation.
  • H3K9me3 levels increased, suggesting a failure to remove repressive chromatin marks.
  • JAK inhibition (using AG490 or SD1029) recapitulated these epigenetic defects.
• Functional Validation of ISGs:
  • Knockdown of IFI16, IFITM1, IFITM2, and IFITM3 did not immediately induce differentiation but significantly reduced colony number and size (proliferation defect) during both reprogramming initiation and maintenance.
  • These genes are enriched in human pre-implantation epiblasts and various naïve culture conditions (TL2i, 4CL, PXGL).

5. Significance

• Mechanistic Insight: The study resolves a key debate by showing that in human cells, the chromatin accessibility provided by JAK signaling is the prerequisite for STAT3-mediated transcription. Unlike in mouse cells where STAT3 activation alone suffices, human primed cells require JAK-mediated epigenetic remodeling to access the naïve state.
• Novel Regulators: The identification of IFI16 and IFITM family proteins as critical regulators of naïve pluripotency is a major finding. It suggests a link between innate immune pathways (interferon signaling) and the maintenance of the pluripotent state, potentially serving as a defense mechanism to protect the germline genome integrity.
• Platform for Discovery: The G-CSFR:gp130 genetic switch provides a powerful, LIF-independent tool to dissect signaling dynamics and screen for regulators of human naïve pluripotency without the confounding effects of complex chemical inhibitors.
• Therapeutic Implications: Understanding the specific role of JAK and interferon pathways in human stem cells could inform strategies for improving the derivation and stability of naïve hPSCs for regenerative medicine and disease modeling.